ArticleThe oncologist2026

Correction to: Clinical characteristics of the ALK fusion-positive bladder PMP and efficacy of lorlatinib: a two-case report and literature review.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.